305 related articles for article (PubMed ID: 20142103)
1. Suppression of Wnt signaling by Dkk1 attenuates PTH-mediated stromal cell response and new bone formation.
Guo J; Liu M; Yang D; Bouxsein ML; Saito H; Galvin RJ; Kuhstoss SA; Thomas CC; Schipani E; Baron R; Bringhurst FR; Kronenberg HM
Cell Metab; 2010 Feb; 11(2):161-71. PubMed ID: 20142103
[TBL] [Abstract][Full Text] [Related]
2. Targeted overexpression of Dkk1 in osteoblasts reduces bone mass but does not impair the anabolic response to intermittent PTH treatment in mice.
Yao GQ; Wu JJ; Troiano N; Insogna K
J Bone Miner Metab; 2011 Mar; 29(2):141-8. PubMed ID: 20602130
[TBL] [Abstract][Full Text] [Related]
3. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
4. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
[TBL] [Abstract][Full Text] [Related]
5. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L
J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436
[TBL] [Abstract][Full Text] [Related]
6. PTH/cAMP/PKA signaling facilitates canonical Wnt signaling via inactivation of glycogen synthase kinase-3beta in osteoblastic Saos-2 cells.
Suzuki A; Ozono K; Kubota T; Kondou H; Tachikawa K; Michigami T
J Cell Biochem; 2008 May; 104(1):304-17. PubMed ID: 17990294
[TBL] [Abstract][Full Text] [Related]
7. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.
Li J; Sarosi I; Cattley RC; Pretorius J; Asuncion F; Grisanti M; Morony S; Adamu S; Geng Z; Qiu W; Kostenuik P; Lacey DL; Simonet WS; Bolon B; Qian X; Shalhoub V; Ominsky MS; Zhu Ke H; Li X; Richards WG
Bone; 2006 Oct; 39(4):754-66. PubMed ID: 16730481
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-185 inhibits the growth and proliferation of osteoblasts in fracture healing by targeting PTH gene through down-regulating Wnt/β -catenin axis: In an animal experiment.
Yao CJ; Lv Y; Zhang CJ; Jin JX; Xu LH; Jiang J; Geng B; Li H; Xia YY; Wu M
Biochem Biophys Res Commun; 2018 Jun; 501(1):55-63. PubMed ID: 29678580
[TBL] [Abstract][Full Text] [Related]
9. [Parathyroid hormone and Wnt signaling].
Tamura Y; Kaji H
Clin Calcium; 2013 Jun; 23(6):847-52. PubMed ID: 23719497
[TBL] [Abstract][Full Text] [Related]
10. Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms.
Jilka RL; O'Brien CA; Bartell SM; Weinstein RS; Manolagas SC
J Bone Miner Res; 2010 Nov; 25(11):2427-37. PubMed ID: 20533302
[TBL] [Abstract][Full Text] [Related]
11. The roles of Wnt signaling modulators Dickkopf-1 (Dkk1) and Dickkopf-2 (Dkk2) and cell maturation state in osteogenesis on microstructured titanium surfaces.
Olivares-Navarrete R; Hyzy S; Wieland M; Boyan BD; Schwartz Z
Biomaterials; 2010 Mar; 31(8):2015-24. PubMed ID: 20004015
[TBL] [Abstract][Full Text] [Related]
12. The effects of Dickkopf-4 on the proliferation, differentiation, and apoptosis of osteoblasts.
Hiramitsu S; Terauchi M; Kubota T
Endocrinology; 2013 Dec; 154(12):4618-26. PubMed ID: 24105477
[TBL] [Abstract][Full Text] [Related]
13. Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation.
Clines GA; Mohammad KS; Bao Y; Stephens OW; Suva LJ; Shaughnessy JD; Fox JW; Chirgwin JM; Guise TA
Mol Endocrinol; 2007 Feb; 21(2):486-98. PubMed ID: 17068196
[TBL] [Abstract][Full Text] [Related]
14. Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease.
Carrillo-López N; Panizo S; Alonso-Montes C; Román-García P; Rodríguez I; Martínez-Salgado C; Dusso AS; Naves M; Cannata-Andía JB
Kidney Int; 2016 Jul; 90(1):77-89. PubMed ID: 27165819
[TBL] [Abstract][Full Text] [Related]
15. Influence of Calcium Supplementation against Fluoride-Mediated Osteoblast Impairment in Vitro: Involvement of the Canonical Wnt/β-Catenin Signaling Pathway.
Wang J; Yang J; Cheng X; Yin F; Zhao Y; Zhu Y; Yan Z; Khodaei F; Ommati MM; Manthari RK; Wang J
J Agric Food Chem; 2019 Sep; 67(37):10285-10295. PubMed ID: 31443611
[TBL] [Abstract][Full Text] [Related]
16. Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts.
Kamiya N; Kobayashi T; Mochida Y; Yu PB; Yamauchi M; Kronenberg HM; Mishina Y
J Bone Miner Res; 2010 Feb; 25(2):200-10. PubMed ID: 19874086
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects.
Yao W; Cheng Z; Shahnazari M; Dai W; Johnson ML; Lane NE
J Bone Miner Res; 2010 Feb; 25(2):190-9. PubMed ID: 19594295
[TBL] [Abstract][Full Text] [Related]
18. [Effect of signal-selective parathyroid hormone analogue peptide on expressions of Wnt signaling factors].
Feng R; Jiang J; Li J; Fu Z; Lin Z; Yuan L; Yang D
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2012 Apr; 26(4):472-6. PubMed ID: 22568332
[TBL] [Abstract][Full Text] [Related]
19. Loss-of-function of ACVR1 in osteoblasts increases bone mass and activates canonical Wnt signaling through suppression of Wnt inhibitors SOST and DKK1.
Kamiya N; Kaartinen VM; Mishina Y
Biochem Biophys Res Commun; 2011 Oct; 414(2):326-30. PubMed ID: 21945937
[TBL] [Abstract][Full Text] [Related]
20. Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1.
Zhang J; Tu Q; Bonewald LF; He X; Stein G; Lian J; Chen J
J Bone Miner Res; 2011 Aug; 26(8):1953-63. PubMed ID: 21351149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
